Literature DB >> 12773734

Development and destruction of the first state funded anti-smoking campaign in the USA.

T H Tsoukalas1, S A Glantz.   

Abstract

BACKGROUND: Minnesota was the first state in the USA to implement a large state funded tobacco control programme (in 1985). Despite evidence of effectiveness, it was dismantled in 1993.
OBJECTIVE: To describe and analyse how and why these events transpired and identify lessons for tobacco control advocates facing similar challenges in the 21st century.
DESIGN: Case study based on previously secret tobacco industry documents, news reports, research reports, official documents, and interviews with health advocates and state government officials.
RESULTS: Unable to defeat funding for this campaign in 1985, the tobacco industry organised groups which eliminated it later. Despite the programme's documented effectiveness, it was dismantled based on claims of fiscal crisis. These claims were not true; the real debate was what to do with the state's surplus. Health advocates failed to challenge the claim of fiscal crisis or mobilise public support for the programme.
CONCLUSIONS: Simply quoting evidence that a tobacco control programme is effective does not ensure its continuing survival. Claims of fiscal crisis are an effective cover for tobacco industry efforts to dismantle successful programmes, particularly if health advocates accept these claims and fail to mobilise political pressure to defend the programme.

Entities:  

Mesh:

Year:  2003        PMID: 12773734      PMCID: PMC1747722          DOI: 10.1136/tc.12.2.214

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  18 in total

Review 1.  The passage and initial implementation of Oregon's Measure 44.

Authors:  L K Goldman; S A Glantz
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

2.  Who's afraid of the truth?

Authors:  C Healton
Journal:  Am J Public Health       Date:  2001-04       Impact factor: 9.308

3.  A computer simulation model of mass media interventions directed at tobacco use.

Authors:  D T Levy; K Friend
Journal:  Prev Med       Date:  2001-03       Impact factor: 4.018

Review 4.  Effectiveness of comprehensive tobacco control programmes in reducing teenage smoking in the USA.

Authors:  M Wakefield; F Chaloupka
Journal:  Tob Control       Date:  2000-06       Impact factor: 7.552

5.  The Minnesota Plan for Nonsmoking and Health: the legislative experience.

Authors:  J M Shultz; M E Moen; T F Pechacek; K C Harty; M A Skubic; S W Gust; A G Dean
Journal:  J Public Health Policy       Date:  1986       Impact factor: 2.222

6.  Failure to defend a successful state tobacco control program: policy lessons from Florida.

Authors:  M S Givel; S A Glantz
Journal:  Am J Public Health       Date:  2000-05       Impact factor: 9.308

Review 7.  The politics of antismoking legislation.

Authors:  P D Jacobson; J Wasserman; K Raube
Journal:  J Health Polit Policy Law       Date:  1993       Impact factor: 2.265

8.  Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease.

Authors:  C M Fichtenberg; S A Glantz
Journal:  N Engl J Med       Date:  2000-12-14       Impact factor: 91.245

9.  Tobacco industry allegations of "illegal lobbying" and state tobacco control.

Authors:  S A Bialous; B J Fox; S A Glantz
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

Review 10.  Arizona's tobacco control initiative illustrates the need for continuing oversight by tobacco control advocates.

Authors:  S Aguinaga Bialous; S A Glantz
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

View more
  15 in total

1.  How state counter-industry campaigns help prime perceptions of tobacco industry practices to promote reductions in youth smoking.

Authors:  J C Hersey; J Niederdeppe; S W Ng; P Mowery; M Farrelly; P Messeri
Journal:  Tob Control       Date:  2005-12       Impact factor: 7.552

2.  Point of purchase cigarette promotions before and after the Master Settlement Agreement: exploring retail scanner data.

Authors:  B R Loomis; M C Farrelly; J M Nonnemaker; N H Mann
Journal:  Tob Control       Date:  2006-04       Impact factor: 7.552

3.  Tobacco industry litigation strategies to oppose tobacco control media campaigns.

Authors:  J K Ibrahim; Stanton A Glantz
Journal:  Tob Control       Date:  2006-02       Impact factor: 7.552

4.  Labor unions: a public health institution.

Authors:  Beth Malinowski; Meredith Minkler; Laura Stock
Journal:  Am J Public Health       Date:  2015-02       Impact factor: 9.308

Review 5.  The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries.

Authors:  Sungkyu Lee; Pamela M Ling; Stanton A Glantz
Journal:  Cancer Causes Control       Date:  2012-02-28       Impact factor: 2.506

Review 6.  'We will speak as the smoker': the tobacco industry's smokers' rights groups.

Authors:  Elizabeth A Smith; Ruth E Malone
Journal:  Eur J Public Health       Date:  2006-10-25       Impact factor: 3.367

7.  The association between the socioeconomic status and systemic comorbidities in patients with oral cancers: a retrospective study in Guangxi Province.

Authors:  Zhuoqian Zhou; Qinchao Tang; Xueru Chen; Tao Yu; Wanqian Huang; Feixin Liang
Journal:  Clin Oral Investig       Date:  2020-06-22       Impact factor: 3.573

8.  Tobacco industry attempts to counter the World Bank report Curbing the Epidemic and obstruct the WHO framework convention on tobacco control.

Authors:  Hadii M Mamudu; Ross Hammond; Stanton Glantz
Journal:  Soc Sci Med       Date:  2008-10-22       Impact factor: 4.634

9.  Public health foundations and the tobacco industry: lessons from Minnesota.

Authors:  J K Ibrahim; T H Tsoukalas; S A Glantz
Journal:  Tob Control       Date:  2004-09       Impact factor: 7.552

10.  The role of public policies in reducing smoking: the Minnesota SimSmoke tobacco policy model.

Authors:  David T Levy; Raymond G Boyle; David B Abrams
Journal:  Am J Prev Med       Date:  2012-11       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.